In conclusion, our study offers the first comprehensive evidence that the TRIM59-IRF6-PGM1 pathway plays a crucial role in glycolysis-induced tumorigenesis in neuroblastoma cells and may serve as a target for neuroblastoma therapy and prognosis. Here, IRF6 is linked to neuroblastoma.